• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

手术及围手术期因素对接受肝切除术的原发性肝癌患者长期预后的影响。

Impact of operative and peri-operative factors on the long-term prognosis of primary liver cancer patients undergoing hepatectomy.

作者信息

Xu Li-Ning, Xu Ying-Ying, Gao De-Wei

机构信息

Department of General Surgery, Clinical Division of South Building, Chinese PLA General Hospital, Beijing, 100853, China.

Department of Internal Medicine, Henan Cancer Hospital, Zhengzhou, 450003, China.

出版信息

J Huazhong Univ Sci Technolog Med Sci. 2016 Aug;36(4):523-528. doi: 10.1007/s11596-016-1619-2. Epub 2016 Jul 28.

DOI:10.1007/s11596-016-1619-2
PMID:27465327
Abstract

This study examined the impact of the operative and peri-operative factors on the long-term prognosis of patients with primary liver cancer undergoing hepatectomy. A total of 222 patients with primary liver cancer who underwent hepatectomy were followed up from January 1986 to December 2010 at Chinese PLA General Hospital. The post-operative complication rate was 14.0% for all cases, 13.7% for hepatocellular carcinoma (HCC), 10.0% for cholangiocarcinoma. The 1-, 3-, 5- and 10-year overall survival rates in patients with primary liver cancer after resection were 76.6%, 57.6%, 41.4%, and 21.0%. The survival rates were significantly higher in the HCC group than in the cholangiocarcinoma group (P=0.000), in the non-anatomical resection group than in the anatomical resection group (P=0.005), in the female group than in the male group (P=0.002), in patients receiving no blood transfusion than in those who were given intra-operative blood transfusion (P=0.000), in patients whose intra-operative blood loss was less than 400 mL than in those who intra-operatively lost more than 400 mL (P=0.000). No significant difference was found in the survival rate between the HBsAg-positive group and the HBsAg-negative group (P=0.532). Our study showed that anatomical resection, blood loss and blood transfusion were predictors of poor survival after hepatectomy for primary liver cancer patients, and concomitant hepatitis B virus infection bore no relation with the post-resection survival.

摘要

本研究探讨了手术及围手术期因素对接受肝切除术的原发性肝癌患者长期预后的影响。1986年1月至2010年12月,解放军总医院对222例行肝切除术的原发性肝癌患者进行了随访。所有病例的术后并发症发生率为14.0%,肝细胞癌(HCC)为13.7%,胆管癌为10.0%。原发性肝癌患者切除术后1年、3年、5年和10年的总生存率分别为76.6%、57.6%、41.4%和21.0%。HCC组的生存率显著高于胆管癌组(P = 0.000),非解剖性切除组高于解剖性切除组(P = 0.005),女性组高于男性组(P = 0.002),未输血患者高于术中输血患者(P = 0.000),术中失血少于400 mL的患者高于术中失血超过400 mL的患者(P = 0.000)。HBsAg阳性组和HBsAg阴性组的生存率无显著差异(P = 0.532)。我们的研究表明,解剖性切除、失血和输血是原发性肝癌患者肝切除术后生存不良的预测因素,而乙型肝炎病毒感染与切除术后生存无关。

相似文献

1
Impact of operative and peri-operative factors on the long-term prognosis of primary liver cancer patients undergoing hepatectomy.手术及围手术期因素对接受肝切除术的原发性肝癌患者长期预后的影响。
J Huazhong Univ Sci Technolog Med Sci. 2016 Aug;36(4):523-528. doi: 10.1007/s11596-016-1619-2. Epub 2016 Jul 28.
2
The long-term outcomes after curative resection for mass-forming intrahepatic cholangiocarcinoma associated with hepatitis C viral infection: a multicenter analysis by Osaka Hepatic Surgery Study Group.根治性切除术后伴丙型肝炎病毒感染的肿块型肝内胆管细胞癌的长期预后:大阪肝脏外科学会的多中心分析。
J Surg Oncol. 2014 Aug;110(2):176-81. doi: 10.1002/jso.23611. Epub 2014 Apr 24.
3
Hepatic resection for combined hepatocellular and cholangiocarcinoma.肝细胞癌合并胆管癌的肝切除术。
Arch Surg. 2003 Jan;138(1):86-90.
4
Hepatitis B virus-related combined hepatocellular-cholangiocarcinoma: clinicopathological and prognostic analysis of 390 cases.乙型肝炎病毒相关的肝细胞-胆管细胞癌:390 例的临床病理和预后分析。
Eur J Gastroenterol Hepatol. 2014 Feb;26(2):192-9. doi: 10.1097/MEG.0b013e3283625df9.
5
Prognostic roles of preoperative α-fetoprotein and des-γ-carboxy prothrombin in hepatocellular carcinoma patients.术前甲胎蛋白和脱γ-羧基凝血酶原在肝细胞癌患者中的预后作用
World J Gastroenterol. 2015 Apr 28;21(16):4933-45. doi: 10.3748/wjg.v21.i16.4933.
6
Surgical Outcomes of Hepatic Resection for Hepatitis B Virus Surface Antigen-Negative and Hepatitis C Virus Antibody-Negative Hepatocellular Carcinoma.乙型肝炎病毒表面抗原阴性和丙型肝炎病毒抗体阴性肝细胞癌肝切除的手术结果
Ann Surg Oncol. 2015 Jul;22(7):2279-85. doi: 10.1245/s10434-014-4261-x. Epub 2014 Dec 4.
7
Comparison of combined hepatocellular and cholangiocarcinoma with hepatocellular carcinoma and intrahepatic cholangiocarcinoma.肝细胞癌合并胆管癌与肝细胞癌及肝内胆管癌的比较。
Surg Today. 2006;36(10):892-7. doi: 10.1007/s00595-006-3276-8.
8
Combined hepatocellular carcinoma and cholangiocarcinoma: clinical features, treatment modalities, and prognosis.肝细胞癌合并胆管细胞癌:临床特征、治疗方式和预后。
Ann Surg Oncol. 2012 Sep;19(9):2869-76. doi: 10.1245/s10434-012-2328-0. Epub 2012 Mar 27.
9
Poor oncologic outcomes of hepatocellular carcinoma patients with intra-abdominal infection after hepatectomy.肝癌患者肝切除术后发生腹腔内感染的肿瘤学预后较差。
World J Gastroenterol. 2015 May 14;21(18):5598-606. doi: 10.3748/wjg.v21.i18.5598.
10
[Impact of surgical operation-related factors on long-term survival of patients with hepatocellular carcinoma after hepatectomy].[手术相关因素对肝癌肝切除术后患者长期生存的影响]
Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2008 Aug;30(4):386-92.

引用本文的文献

1
Establishment of a risk assessment system for complications of hepatectomy based on preoperative variables.基于术前变量建立肝切除术后并发症风险评估系统。
ILIVER. 2022 Oct 28;1(4):217-224. doi: 10.1016/j.iliver.2022.09.004. eCollection 2022 Dec.
2
Short-term efficacy of microwave ablation in the treatment of liver cancer and its effect on immune function.微波消融治疗肝癌的短期疗效及其对免疫功能的影响。
World J Clin Cases. 2024 Jun 26;12(18):3395-3402. doi: 10.12998/wjcc.v12.i18.3395.
3
Negative Impact of Intra-Operative Blood Transfusion on Survival Outcomes of Hepatocellular Carcinoma Patients.

本文引用的文献

1
Surveillance, diagnosis, treatment, and outcome of liver cancer in Japan.日本肝癌的监测、诊断、治疗及预后
Liver Cancer. 2015 Mar;4(1):39-50. doi: 10.1159/000367727.
2
Comparison between disease free survival of hepatocellular carcinoma after hepatic resection in chronic hepatitis B patients with or without cirrhosis.慢性乙型肝炎伴或不伴肝硬化患者肝切除术后肝细胞癌无病生存期的比较。
J Med Assoc Thai. 2015 Apr;98(4):334-42.
3
International trends in primary liver cancer incidence from 1973 to 2007.1973年至2007年原发性肝癌发病率的国际趋势。
术中输血对肝细胞癌患者生存结局的负面影响
Cancer Manag Res. 2024 Apr 25;16:385-393. doi: 10.2147/CMAR.S448629. eCollection 2024.
4
Efficacy of a modified FRAIL scale in predicting the peri-operative outcome of hepatectomy in older adults (aged ≥ 75 years): a model development study.改良 FRAIL 量表在预测老年(≥75 岁)人群肝切除围手术期结局中的作用:模型建立研究。
BMC Geriatr. 2023 Nov 23;23(1):770. doi: 10.1186/s12877-023-04488-8.
5
Perioperative factors related to the prognosis of elderly patients with hepatocellular carcinoma.与老年肝细胞癌患者预后相关的围手术期因素。
Eur J Med Res. 2022 Dec 9;27(1):280. doi: 10.1186/s40001-022-00896-5.
6
Effect of perioperative factors on the prognosis of patients with hepatocellular carcinoma who underwent hepatectomy.围手术期因素对接受肝切除术的肝细胞癌患者预后的影响。
Turk J Med Sci. 2022 Aug;52(4):1067-1074. doi: 10.55730/1300-0144.5409. Epub 2022 Aug 10.
7
Individualized risk estimation for postoperative pulmonary complications after hepatectomy based on perioperative variables.基于围手术期变量的肝切除术后肺部并发症个体化风险评估
World J Gastrointest Surg. 2022 Jul 27;14(7):685-695. doi: 10.4240/wjgs.v14.i7.685.
8
Impact of intramuscular adipose tissue content on short- and long-term outcomes of hepatectomy for colorectal liver metastasis: a retrospective analysis.肌肉内脂肪组织含量对结直肠肝转移瘤肝切除术后近期和远期结局的影响:一项回顾性分析。
World J Surg Oncol. 2020 Apr 7;18(1):68. doi: 10.1186/s12957-020-01836-5.
9
The impact of perioperative allogeneic blood transfusion on prognosis of hepatocellular carcinoma after radical hepatectomy: A systematic review and meta-analysis of cohort studies.围手术期异体输血对根治性肝切除术后肝细胞癌预后的影响:队列研究的系统评价和荟萃分析
Medicine (Baltimore). 2018 Oct;97(43):e12911. doi: 10.1097/MD.0000000000012911.
10
Pancreatic neuroendocrine neoplasms: Correlation between MR features and pathological tumor grades.胰腺神经内分泌肿瘤:磁共振成像特征与肿瘤病理分级的相关性
J Huazhong Univ Sci Technolog Med Sci. 2017 Aug;37(4):587-595. doi: 10.1007/s11596-017-1777-x. Epub 2017 Aug 8.
BMC Cancer. 2015 Mar 4;15:94. doi: 10.1186/s12885-015-1113-4.
4
Effect of liver regeneration on malignant hepatic tumors.肝再生对恶性肝肿瘤的影响。
World J Gastroenterol. 2014 Nov 21;20(43):16167-77. doi: 10.3748/wjg.v20.i43.16167.
5
Practice to minimize the use of blood products improve outcome after hepatic resection for hepatocellular carcinoma.通过实践尽量减少血制品的使用可改善肝细胞癌肝切除术后的预后。
Hepatogastroenterology. 2013 Oct;60(127):1681-3.
6
Management of post-hepatectomy complications.肝切除术后并发症的处理。
World J Gastroenterol. 2013 Nov 28;19(44):7983-91. doi: 10.3748/wjg.v19.i44.7983.
7
A comprehensive meta-regression analysis on outcome of anatomic resection versus nonanatomic resection for hepatocellular carcinoma.解剖性肝切除术与非解剖性肝切除术治疗肝细胞癌结局的全面荟萃回归分析。
Ann Surg Oncol. 2012 Nov;19(12):3697-705. doi: 10.1245/s10434-012-2450-z. Epub 2012 Jun 22.
8
Combined hepatocellular carcinoma and cholangiocarcinoma: clinical features, treatment modalities, and prognosis.肝细胞癌合并胆管细胞癌:临床特征、治疗方式和预后。
Ann Surg Oncol. 2012 Sep;19(9):2869-76. doi: 10.1245/s10434-012-2328-0. Epub 2012 Mar 27.
9
Meta-analysis of anatomic resection versus nonanatomic resection for hepatocellular carcinoma.解剖性肝切除术与非解剖性肝切除术治疗肝细胞癌的荟萃分析。
Langenbecks Arch Surg. 2011 Oct;396(7):1109-17. doi: 10.1007/s00423-011-0784-9. Epub 2011 Apr 8.
10
Survival after anatomic resection versus nonanatomic resection for hepatocellular carcinoma: a meta-analysis.解剖性肝切除术与非解剖性肝切除术治疗肝细胞癌的生存比较:一项荟萃分析。
Dig Dis Sci. 2011 Jun;56(6):1626-33. doi: 10.1007/s10620-010-1482-0. Epub 2010 Nov 17.